logo
What Happens If Your Kidneys Fail? Signs and Complications

What Happens If Your Kidneys Fail? Signs and Complications

Health Line12-07-2025
Key takeaways
Kidney failure occurs when the kidneys can no longer filter waste and excess fluid from the blood, leading to a buildup of toxins in the body.
Symptoms of kidney failure can include swelling, fatigue, changes in urination, and confusion.
Without medical treatment, life expectancy after kidney failure is typically a few weeks, but dialysis or a kidney transplant can significantly extend a person's life.
If you have chronic kidney disease (CKD), your kidneys cannot filter waste and excess fluid from your blood as well as they should. But kidney disease is not the same as kidney failure.
End-stage kidney failure means important body functions are compromised. You'll feel sick. Your life will even be at risk without medical treatment.
CKD is a progressive disease that develops in five stages, meaning that your kidney function gets worse over time.
Kidney failure is the fifth and final stage of CKD. Some healthcare professionals call it end-stage renal disease (ESRD).
It is possible to stop the progression of CKD before it reaches the fifth stage for some people. Others may not be aware they have CKD until their kidneys fail.
Although there's currently no cure for CKD, you can take some steps to slow disease progression and prevent kidney failure.
If your kidneys fail, they're no longer able to work on their own, but treatment is available that can help you live longer.
What happens when you have kidney disease?
The effects of kidney disease on the body may vary depending on the stage of CKD. If you have CKD, your kidneys will progressively lose the ability to perform their functions.
The main job of the kidneys is to filter waste and excess fluid from the blood and balance salts and minerals like calcium, potassium, and sodium. Kidneys also produce hormones that your body needs to:
manage blood pressure
make red blood cells
keep bones strong
Living with CKD increases the chances of developing:
high blood pressure (hypertension)
heart disease
anemia
gout
excess potassium in the blood (hyperkalemia)
metabolic acidosis
immune system challenges
bone disease
You may not have any symptoms or mild symptoms during the early stages of CKD, but you will start feeling sick as your kidneys fail.
How do you know if your kidneys are failing?
When your kidneys fail, you may develop generalized symptoms related to kidney functions. These can vary in intensity.
Healthcare professionals consider you to be in the stage of kidney failure when your kidney function is reduced to 15% or less.
Kidney failure signs and symptoms may include:
dark urine
edema (swelling) in your ankles, legs, and feet
persistent or recurrent headaches
itchy skin
restless legs
unexplained fatigue (low energy)
sleep disturbances
digestive symptoms like nausea
little or no urine
muscle cramps
generalized aches and pains
cognitive challenges like trouble focusing or remembering information
Symptoms of end-stage kidney failure may include:
pain in your bones
vomiting
unintended weight loss
changes in skin color and texture
loss of appetite
mental confusion
nosebleeds
an inability to urinate
What are the signs of dying from kidney failure?
If you have kidney failure, you're left with about 10–15% of your kidney function. At this point, your kidneys can no longer function on their own.
You may experience more severe and persistent symptoms, in addition to:
fever
seizures
coma
How long can you live if your kidneys fail?
Without any medical treatment, life expectancy after kidney failure is only a few weeks.
While there's no way to undo kidney failure, treatment in the form of dialysis or kidney transplant may help you live longer. In fact, once you reach end-stage kidney failure, you need medical treatment to survive.
According to the National Kidney Foundation, the average life expectancy for people on dialysis is 5–10 years. Some people receive dialysis for as long as 30 years.
Many factors can affect life expectancy if you have kidney failure. Lifestyle changes and medications can help improve your quality of life. For example:
getting regular medical check-ups
following your doctor's recommendations and treatment plan
focusing on a nutrient-dense diet
daily physical activity
managing related conditions, such as diabetes or high blood pressure
Can you survive if both kidneys fail?
Most people can survive with one healthy kidney. If both of your kidneys fail, you'll need dialysis or a kidney transplant.
Dietary changes and regular exercise may help your treatments work better. Your diet is key to maintaining the proper balance of salts, fluids, and minerals in your body.
Exercise strengthens your body and brings oxygen to your tissues. It can also improve your mood and help you sleep at night.
What treatments are available for kidney failure?
Dialysis
Dialysis does the work your kidneys no longer can, filtering your blood to remove waste products. There are two types of dialysis: hemodialysis and peritoneal dialysis.
Hemodialysis
During hemodialysis, your blood goes through an external filter containing a dialysis solution that removes waste and excess water. Your blood leaves your body and then returns via needles in your arm.
You can have hemodialysis at a dialysis center or at home.
Peritoneal dialysis
With peritoneal dialysis, a surgeon inserts a catheter into your abdomen. Dialysis solution from a bag enters your abdomen through the catheter. Once the bag is empty, you disconnect it and cap the catheter. You can then carry on with everyday activities.
The dialysis solution in your abdomen absorbs waste and excess fluid from your body.
After several hours, you drain and discard the used dialysis solution through the catheter into an empty bag. You may need to repeat this process 4–6 times a day.
You can perform this type of dialysis anywhere. It can also work while you're sleeping with the help of a machine called a cycler.
Kidney transplant
A kidney transplant is a surgical procedure in which one or both of your kidneys are replaced with a donor kidney. A transplant can be from a living or deceased donor. Your doctor can guide you through the process of finding a living donor or getting on a waitlist.
A successful kidney transplant may help you to live longer than if you remained on dialysis. In many cases, donor recipients can live the way they did before they had kidney disease.
As with any surgery, risks with transplant surgery are possible. You'll also need to take anti-rejection medication to protect your new kidney from your immune system.
This type of medication increases your risk of infection and some types of cancer.
The takeaway
When your kidneys stop working, you'll need medical treatment to survive. Life expectancy is often reduced to a few weeks if your kidneys fail. However, treatment is available and usually effective to help you feel better and live longer.
Signs your kidneys are failing may include swelling, itchiness, aches and pains, weight loss, an inability to urinate, and confusion. Coma is possible in the end stages of kidney failure.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow
UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow

Yahoo

time2 hours ago

  • Yahoo

UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A senior healthcare professional giving advice to a patient in a clinic. The stock has dropped over 44% so far this year after reporting weaker-than-expected earnings in the first quarter. The company first reduced its full-year outlook and later chose to withdraw it entirely. Even with the underwhelming Q1 performance, UnitedHealth Group Incorporated (NYSE:UNH) still posted a 9.8% year-over-year increase in revenue, reaching $109.6 billion. It earned a profit of around $6.3 billion during the quarter and maintained a solid financial position, holding close to $34.3 billion in cash and cash equivalents, along with a debt level that remains manageable. The company has added 780,000 new members so far this year. Meanwhile, Optum Health still expects to provide value-based care to an additional 650,000 patients in 2025. In addition, UnitedHealth Group Incorporated (NYSE:UNH) generated $5.5 billion in operating cash flow during the quarter and returned $5 billion to investors through dividends and share repurchases. The company has been rewarding shareholders with growing dividends since 2011 and currently offers a quarterly dividend of $2.21 per share. The stock supports a dividend yield of 3.15%, as of July 26. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage
Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage

Forbes

time3 hours ago

  • Forbes

Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage

There were two major announcements recently regarding prior approval of treatments and services for Medicare beneficiaries. In most medical insurance, many treatments won't be covered unless it is approved first by the insurer. It's been a source of controversy for some time. Original Medicare hasn't required prior authorization of treatments and services, with a few exceptions. For most care, providers and the patient agree on a treatment. After the treatment, paperwork for approval and payment is submitted to Medicare. Medicare recently announced a new model program that will test pre-approval. The voluntary model program will test pre-approval for some services and treatments, according to a recent announcement from the Center for Innovation of the Centers for Medicare and Medicaid Services. The model program is seeking medical providers to volunteer for the program from Jan. 1, 2026 through Dec. 31, 2031. The model will be restricted to New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Providers who volunteer and are accepted will agree to seek prior authorization for 17 items and services, including skin substitutes, deep brain stimulation for Parkinson's Disease, impotence treatment, and arthroscopy for knee osteoarthritis. A provider who volunteers for the program can choose not to seek prior approval for a case. There will be a post-treatment review of the case, and the provider will risk not being paid by Medicare for the treatment. CMS initiated the program and selected the services to be covered because of a series of reports showing waste, fraud or abuse in certain areas. For example, Medicare spent up to $5.8 billion in 2022 on unnecessary or inappropriate services that had no clinical benefit, according to the Medicare Payment Advisory Commission. Under the model, providers will submit the same information they currently submit for payment approval after a service is provided to a beneficiary. The difference is that under the model, the information will be submitted earlier and the provider will wait for approval before performing the services. CMS will select companies to receive and review the prior authorizations. It expects that they will use artificial intelligence and other tools in addition to medical professionals to review the submissions. The companies will be paid based on the extent to which they saved the government money by stopping unnecessary services. CMS said it will manage the program to avoid adverse impact on beneficiaries and providers. There was other news about pre-approval, this time involving Medicare Advantage plans. Pre-approval in Medicare Advantage plans has been controversial recently. There have been a number of recent reports and studies that found the authorization process was delaying treatment or causing patients to abandon treatment plans. Other reports indicated that a high percentage of treatments that initially were denied coverage eventually were approved if the patients or their providers appealed the than 50 major insurers who sponsor many types of insurance plans announced that they will voluntarily streamline prior authorization of treatments and services in all insurance markets, including Medicare Advantage plans. The insurers say they plan to have the new process in place by Jan. 1, 2027.

Labcorp Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Labcorp Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo

time4 hours ago

  • Yahoo

Labcorp Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Labcorp Holdings (NYSE:LH) Second Quarter 2025 Results Key Financial Results Revenue: US$3.53b (up 9.5% from 2Q 2024). Net income: US$237.9m (up 16% from 2Q 2024). Profit margin: 6.7% (up from 6.4% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$2.85 (up from US$2.44 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Labcorp Holdings Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) missed analyst estimates by 12%. Looking ahead, revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are up 8.7% from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Labcorp Holdings. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store